BLOG

Targeting a Key Marker of Clotting and Inflammation in COVID-19 Patients

CalciMedica has developed Auxora, a calcium release-activated calcium (CRAC) channel inhibitor, and it has shown it can reduce the levels of D-dimer, a key biomarker associated with COVID-19 mortality.